Open AccessThis article is
- freely available
Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases
Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital, 371, Avenue du Doyen Gaston Giraud, Montpellier 34295, France
* Author to whom correspondence should be addressed.
Received: 16 August 2013; in revised form: 10 September 2013 / Accepted: 27 September 2013 / Published: 23 October 2013
Abstract: Multipotent mesenchymal stromal cells or mesenchymal stem cells (MSCs) are adult stem cells exhibiting functional properties that have opened the way for cell-based clinical therapies. MSCs have been reported to exhibit immunosuppressive as well as healing properties, improving angiogenesis and preventing apoptosis or fibrosis through the secretion of paracrine mediators. This review summarizes recent progress on the clinical application of stem cells therapy in some inflammatory and degenerative rheumatic diseases. To date, most of the available data have been obtained in preclinical models and clinical efficacy needs to be evaluated through controlled randomized double-blind trials.
Keywords: mesenchymal stem cells; rheumatic diseases; osteoarthritis; rheumatoid arthritis; autoimmune diseases; immune tolerance
Citations to this Article
Cite This Article
MDPI and ACS Style
Pers, Y.-M.; Jorgensen, C. Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases. J. Clin. Med. 2013, 2, 201-213.
Pers Y-M, Jorgensen C. Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases. Journal of Clinical Medicine. 2013; 2(4):201-213.
Pers, Yves-Marie; Jorgensen, Christian. 2013. "Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases." J. Clin. Med. 2, no. 4: 201-213.